TETRACYCLINE (1131)

Compound Details

NameTETRACYCLINE
Compound class21009162027347799
Compound codePOLYCYCLIC

Summary

Compound class: 21009162027347799

Experiments: 83

View Experiments

Experiments (83)

Filters
Worktypes (44)
72
26
14
10
7
6
6
6
6
6
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (17)
11
4
3
2
2
2
1
1
1
1
1
1
1
1
1
1
49
No match
Compounds (71)
83
7
6
6
5
4
4
4
4
4
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Organisms (66)
11
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
83 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)
327959
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)REVIEW OF
Empty organism
442329
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
327521
IDENTIFICATION OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)TLC DATA REPORTED
Empty organism
442325
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
405968
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANSREVIEW OF
ANTIBACTERIAL ACTIVITY
Empty organism
859092
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
327143
HPLC DATA REPORTEDSEPARATION OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
319162
PHARMACOKINETIC/BIOAVAILABITY STUDYANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
865171
SPECTROPHOTOMETRIC ASSAY OF
Empty organism
330313
PURIFICATION OFPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
318770
PHARMACOKINETIC/BIOAVAILABITY STUDYANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
407100
PARTIAL SYNTHESIS OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
319087
METABOLISM STUDYANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PREPARATION OF LABELLLED COMPOUND
Empty organism
319046
STABILITY STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
1034970
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIAMEBIC ACTIVITY
Empty organism
614333
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
329523
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
329646
COMPLEX FORMATIONPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
442333
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
891196
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMALARIAL ACTIVITY
Empty organism
324912
STRUCTURE DETERMINATION OFSTABILITY STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
329227
PHARMACEUTICAL ANALYSIS OFIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)TLC DATA REPORTED
Empty organism
875281
PHARMACOLOGY OF COMPOUND - IN VIVO
PHARMACOKINETIC STUDY OF
Empty organism
329293
PHARMACOKINETIC/BIOAVAILABITY STUDYANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ABSORPTION/DISTRIBUTION STUDY
Empty organism
331228
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
DETOXIFYING EFFECT(NON-IMMUNOLOGIC)
Empty organism
1243302
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
SPERMICIDAL EFFECT
Empty organism
361370
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
322811
QUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
319062
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
322812
QUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
842085
ASSAY FORTLC DATA REPORTED
Empty organism
325729
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
442335
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFOULING ACTIVITY
Empty organism
442328
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
335980
PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TOXIC EFFECT(GENERAL)
Empty organism
1002268
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIYEAST ACTIVITY
Empty organism
405966
EFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIBACTERIAL ACTIVITY
Empty organism
442327
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
317073
PARTIAL SYNTHESIS OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
331229
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HEPATOTOXIC ACTIVITY
Empty organism
5589
PHARMACOLOGY OF COMPOUND - IN VITRO
ALPHA-AMYLASE INHIBITION
Empty organism
328940
IDENTIFICATION OFPATENT DESCRIBEDQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Streptomyces species (STREPTOMYCETACEAE)
361371
PHARMACOLOGY OF COMPOUND - IN VITRO
MISCELLANEOUS EFFECTS
Empty organism
1186355
PHARMACOLOGY OF COMPOUND - IN VIVO
HEPATOTOXIC ACTIVITY
Empty organism
322813
QUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
442330
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
329390
COMPLEX FORMATIONIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)INDICATION BY COLOR REACTIONS
Empty organism
329387
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)INDICATION BY COLOR REACTIONS
Empty organism
325196
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
317070
PHARMACOKINETIC/BIOAVAILABITY STUDYANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
325368
PARTIAL SYNTHESIS OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
319052
METABOLISM STUDYPHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
329839
PHARMACOKINETIC/BIOAVAILABITY STUDYDISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
319153
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYCOMPLEX FORMATIONIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
325049
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ABSORPTION/DISTRIBUTION STUDY
Empty organism
319074
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ABSORPTION/DISTRIBUTION STUDY
Empty organism
442334
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Empty organism
442326
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
407750
X-RAY CHRYSTALLOGRAPHIC STUDIESSTRUCTURE DETERMINATION OFABSOLUTE CONFIGURATION DETERMINEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
1002269
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIYEAST ACTIVITY
Empty organism
319059
LIQUID-LIQUID SEPARATION MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
319077
INTERACTION IN ANIMALSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
319078
DISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
322814
QUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
442409
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
330826
METABOLISM STUDYEFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
329388
SEPARATION OFPHARMACEUTICAL ANALYSIS OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)TLC DATA REPORTEDPAPER CHROMATOGRAPHY DATA REPORTED
Empty organism
5591
PHARMACOLOGY OF COMPOUND - IN VITRO
ALPHA-AMYLASE INHIBITION
Empty organism
330141
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)INDICATION BY COLOR REACTIONS
Empty organism
442331
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
405683
PHARMACOLOGY OF COMPOUND - IN VITROWORK DESCRIBED MAINLY CONCERNS METHODOLOGYANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
330928
PHARMACOKINETIC/BIOAVAILABITY STUDYANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
1034971
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIAMEBIC ACTIVITY
Empty organism
340983
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
327520
PURIFICATION OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
5590
PHARMACOLOGY OF COMPOUND - IN VITRO
ALPHA-AMYLASE STIMULATION
Empty organism
325392
STRUCTURE DETERMINATION OFCMR SPECTRUM REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
322815
QUANTITATIVE DATA REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
341939
MASS-SPECTRAL FRAGMENTATION REPORTEDFIELD DESORPTION MASS SPECTRUM OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)REVIEW OF
Empty organism
442332
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
442410
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
321070
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OFREVIEW OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
319072
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ABSORPTION/DISTRIBUTION STUDY
Empty organism
Show SPARQL Queries (1)